Synlico Inc.

South San Francisco, CA · Founded 2021 · CIK 0001880583 · Biotech · Private

Causal AI platform that infers disease biology from single-cell patient data to identify drug targets

synlico.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.2M
3 Form D · Feb 2025
19 months since last filing
Contracts
—
No federal contracts on record
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$2,000,040
Private capital raisedForm D · SEC$240,000
Private capital raisedForm D · SEC$3,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2305Congruence Therapeutics——
2306BICYCLE THERAPEUTICS PLC—$555M
2307Gatehouse Bio, Inc.—$5.4M
2308Synlico Inc.—$5.2M
2309Humonix Biosciences Inc——
2310Deep Origin Inc.—$29M
2311Vivace Therapeutics—$61M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Jingwei LuDirector · Executive Officer

Patents

USPTO · 0 granted of 2
  • Machine Learning Based Imputation Of Sequencing Dataapplication
  • Machine Learning Enabled Imputation Of Sequencing Dataapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.